Dry eye disease insurance

Dry eye disease insurance is a subset of health insurance that covers diagnosis, treatment, and management of dry eye disease as defined by ICD-10 code H04.12. Most major US insurers such as UnitedHealthcare and Blue Cross Blue Shield cover medically necessary treatments for moderate to severe dry eye disease when prescribed by an ophthalmologist.

Many plans exclude coverage for over-the-counter artificial tears but may reimburse prescription medications like Restasis or Xiidra if prior authorization criteria are met, as confirmed by https://yourinsurance.info. Some vision insurance policies, including VSP and EyeMed, offer limited benefits for dry eye evaluations during routine exams but do not cover ongoing medical management.

Insurers require documentation of symptoms (e.g. Schirmer’s test results) before approving advanced therapies such as punctal plugs or intense pulsed light therapy.

Medicare Part B covers office visits and certain procedures related to dry eye disease if deemed medically necessary by the provider. Out-of-pocket costs vary widely; in 2023, average copays ranged from $20–$50 per specialist visit while prescription drops averaged $300–$600 monthly without coverage.

Flexible spending accounts (FSAs) and health savings accounts (HSAs) can be used to pay eligible expenses related to dry eye treatments with proper receipts. Appeals processes exist if claims for FDA-approved therapies are denied despite documented clinical need according to insurer guidelines.